EE200300082A - Farmatseutilne kompositsioon urineerimishäire raviks - Google Patents

Farmatseutilne kompositsioon urineerimishäire raviks

Info

Publication number
EE200300082A
EE200300082A EEP200300082A EEP200300082A EE200300082A EE 200300082 A EE200300082 A EE 200300082A EE P200300082 A EEP200300082 A EE P200300082A EE P200300082 A EEP200300082 A EE P200300082A EE 200300082 A EE200300082 A EE 200300082A
Authority
EE
Estonia
Prior art keywords
treating
pharmaceutical composition
urinary disorder
urinary
disorder
Prior art date
Application number
EEP200300082A
Other languages
English (en)
Inventor
Alexander Barden Julian
Gidley-Baird Angus
Original Assignee
Intreat Pty Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intreat Pty Limited filed Critical Intreat Pty Limited
Publication of EE200300082A publication Critical patent/EE200300082A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
EEP200300082A 2000-08-28 2001-08-28 Farmatseutilne kompositsioon urineerimishäire raviks EE200300082A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ9687A AUPQ968700A0 (en) 2000-08-28 2000-08-28 Treatment of urinary incontinence
PCT/AU2001/001079 WO2002017929A1 (en) 2000-08-28 2001-08-28 Treatment of urinary dysfunction

Publications (1)

Publication Number Publication Date
EE200300082A true EE200300082A (et) 2004-12-15

Family

ID=3823741

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300082A EE200300082A (et) 2000-08-28 2001-08-28 Farmatseutilne kompositsioon urineerimishäire raviks

Country Status (19)

Country Link
US (1) US20040067967A1 (et)
EP (1) EP1315503A4 (et)
JP (1) JP2004506744A (et)
KR (1) KR20030034162A (et)
CN (2) CN101164541A (et)
AU (1) AUPQ968700A0 (et)
BR (1) BR0113667A (et)
CA (1) CA2420846A1 (et)
CZ (1) CZ2003807A3 (et)
EA (1) EA007092B1 (et)
EE (1) EE200300082A (et)
HU (1) HUP0300860A3 (et)
IL (1) IL154642A0 (et)
MX (1) MXPA03001833A (et)
NO (1) NO20030978L (et)
NZ (1) NZ537643A (et)
PL (1) PL360368A1 (et)
WO (1) WO2002017929A1 (et)
ZA (1) ZA200302340B (et)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1472376A4 (en) * 2002-01-18 2007-03-21 Millennium Pharm Inc METHOD AND COMPOSITIONS FOR THE TREATMENT OF UROLOGICAL DISEASES USING 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318 , 2058 OR 6351 MO
US20050143323A1 (en) * 2003-12-30 2005-06-30 Henley E. C. Isoflavone therapy for treating urinary incontinence
KR100462173B1 (ko) * 2004-06-08 2004-12-16 안국약품 주식회사 요실금 예방 및 치료용 조성물
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
MX2008002014A (es) * 2005-08-15 2008-03-27 Hoffmann La Roche Derivados de piperidina y piperazina como antagonistas de p2x3.
BRPI0711525A2 (pt) 2006-06-02 2011-11-01 Pear Tree Women S Health Care composição farmacêutica e método para tratar sintomas de vaginite atrófica
AU2007304280B2 (en) * 2006-10-04 2013-01-31 F. Hoffmann-La Roche Ag Process for synthesis of phenoxy diaminopyrimidine derivatives
US8277426B2 (en) 2009-09-30 2012-10-02 Wilcox Heather J Male urinary incontinence device
US12121539B2 (en) 2015-09-11 2024-10-22 Biosceptre (Aust) Pty Ltd Chimeric antigen receptors and uses thereof
MX2019004410A (es) 2016-10-21 2019-09-26 Biosceptre Uk Ltd Particulas citotoxicas.
WO2021065027A1 (ja) * 2019-10-02 2021-04-08 あすか製薬株式会社 排尿障害改善剤
CN118286233A (zh) * 2019-10-02 2024-07-05 Aska制药株式会社 排尿障碍改善剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2566595A (en) * 1994-05-27 1995-12-21 Glaxo Group Limited P-2x receptors (purinoceptor family)
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US5856129A (en) * 1996-10-30 1999-01-05 Incyte Pharmaceuticals, Inc. DNA encoding a human purinoceptor

Also Published As

Publication number Publication date
HUP0300860A3 (en) 2005-03-29
ZA200302340B (en) 2004-06-28
MXPA03001833A (es) 2004-11-01
CN1479621A (zh) 2004-03-03
HUP0300860A2 (hu) 2003-11-28
EA007092B1 (ru) 2006-06-30
IL154642A0 (en) 2003-09-17
CA2420846A1 (en) 2002-03-07
KR20030034162A (ko) 2003-05-01
EP1315503A4 (en) 2005-02-09
EP1315503A1 (en) 2003-06-04
PL360368A1 (en) 2004-09-06
CN101164541A (zh) 2008-04-23
BR0113667A (pt) 2003-06-03
EA200300264A1 (ru) 2003-10-30
AUPQ968700A0 (en) 2000-09-21
NO20030978D0 (no) 2003-02-28
CZ2003807A3 (cs) 2003-08-13
WO2002017929A1 (en) 2002-03-07
NO20030978L (no) 2003-04-16
US20040067967A1 (en) 2004-04-08
JP2004506744A (ja) 2004-03-04
NZ537643A (en) 2006-04-28

Similar Documents

Publication Publication Date Title
DK1524266T3 (da) Farmaceutisk sammensætning
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
PT1307264E (pt) Nova composicao farmaceutica
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
NO20024580D0 (no) Maskin
NO20026196L (no) Kinazolinditosylatsalt-forbindelser
DK1619192T3 (da) Arylkondeserede azapolycykliske forbindelser
ID30536A (id) Komposisi resin untuk cat encer
EP1317933A4 (en) PREPARATIONS FOR WOUND COVERS
ATE267429T1 (de) Übereinstimmungssteuerverfahren
DE60037755D1 (de) Härtbare zusammensetzung
DE60126237D1 (de) Fallstromverflüssiger
FR2808993B1 (fr) Injecteur pour implant souple
DE60016836D1 (de) Resistzusammensetzung
EE200300082A (et) Farmatseutilne kompositsioon urineerimishäire raviks
DE60032946D1 (de) Katheter
DE60104562D1 (de) Bewegungsmechanismus
DE59915132D1 (de) Lithographieverfahren
ATE372338T1 (de) Deshalogenverbindungen
DK1317256T3 (da) Farmaceutisk sammensætning havende en modificeret bærer
DE60132579D1 (de) Raupenplatte
NO20030303L (no) Kalsilytiske forbindelser
ITMI20001848A0 (it) Faramaci per l'incontinenza.
NO20023508D0 (no) Kalsilyttiske forbindelser
NO20031837L (no) Kalsilytiske forbindelser